The North America Spinal Fusion Devices Market would witness Market growth of 3.2% CAGR during the forecast period (2022-2028).
Spine diseases, which range in severity from slight pain & loss of sensitivity to terrible pain and paralysis, are a major source of healthcare expenses around the world. Degenerative problems of the spine, deformity, tumours, and trauma are the most common causes of these disorders.
Degenerative disc disease (DDD) is a type of disorder that is caused by gradual disc damage and often results in disc herniation and chronic back or neck pain. It is most common in people with unhealthy or sedentary lifestyles in their 30s & 40s, and it affects a significant number of people in the various major Market s. Degenerative disc disease (DDD) is the most common surgical disorder badly affecting the spine, and it is caused by repeated pressures that occur as part of the natural aging process. The shock-absorbing intervertebral discs gradually weaken and narrow as DDD progresses. This disorder can affect any part of the spine, but it is most frequent in the cervical & lumbar areas. Osteoarthritis, herniated discs, spinal stenosis, and spondylolysis are a few of the disorders that can result from degenerative disc alterations.
The increasing employment of spine surgery in the United States has been well documented. The rise of the spinal surgery Market in the United States has been aided by technological advancements, elderly patients anticipating improved levels of function, & reimbursement mechanisms that encourage advanced fusion surgery. The annual incidence of spinal cord injury (SCI) in the United States is around 54 instances per one million individuals, or about 17,810 new SCI-related cases each year, And per the 2019 SCI Datasheet from the National Spinal Cord Injury Statistical Center. In the United States, there were lacs of people with spinal cord injuries in 2019. In addition, the American Chiropractic Association estimates that nearly 31 million people in the United States suffer from lower back pain at a certain age in 2018. Spinal problems resulting from obesity, sedentary lifestyle, sports, and accident-related injuries all contribute to an increase in the number of spinal non-fusion procedures.
The US Market dominated the North America Spinal Fusion Devices Market by Country 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $2,367 million by 2028. The Canada Market is exhibiting a CAGR of 5.5% during (2022 - 2028). Additionally, The Mexico Market would witness a CAGR of 4.6% during (2022 - 2028).
Based on Surgery, the Market is segmented into Minimally Invasive Spine Surgery and Open Spine Surgery. Based on Type, the Market is segmented into Thoracolumbar Devices, Cervical Fixation Devices, and Interbody Fusion Devices. Based on End User, the Market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the Market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Spinal Fusion Devices Market is Estimated to reach $9.7 Billion by 2028, at a CAGR of 4.6%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Johnson & Johnson, Stryker Corporation, B. Braun Melsungen AG, Medtronic PLC, Alphatec Holdings Inc., Globus Medical, Inc., NuVasive, Inc., Orthofix Medical, Inc., and Exactech, Inc.
By Surgery
By Type
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
